메뉴 건너뛰기




Volumn 122, Issue 12, 2013, Pages 2003-2007

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AUTOANTIBODY; CARBOPLATIN; COMPLEMENT FACTOR H; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; RITUXIMAB; SARCOLYSIN; SHIGA TOXIN; COMPLEMENT;

EID: 84885717017     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-501445     Document Type: Article
Times cited : (201)

References (30)
  • 1
    • 80051634380 scopus 로고    scopus 로고
    • Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy
    • Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118(6):1452-1462.
    • (2011) Blood , vol.118 , Issue.6 , pp. 1452-1462
    • Laskin, B.L.1    Goebel, J.2    Davies, S.M.3    Jodele, S.4
  • 2
    • 37449023779 scopus 로고    scopus 로고
    • The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation
    • Cooke KR, Jannin A, Ho V. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(1 Suppl 1):23-32.
    • (2008) Biol Blood Marrow Transplant , vol.14 , Issue.1 SUPPL. 1 , pp. 23-32
    • Cooke, K.R.1    Jannin, A.2    Ho, V.3
  • 3
    • 79954441390 scopus 로고    scopus 로고
    • Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy
    • Keir L, Coward RJ. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr Nephrol. 2011;26(4):523-533.
    • (2011) Pediatr Nephrol , vol.26 , Issue.4 , pp. 523-533
    • Keir, L.1    Coward, R.J.2
  • 4
    • 79151471122 scopus 로고    scopus 로고
    • aHUS caused by complement dysregulation: New therapies on the horizon
    • Waters AM, Licht C. aHUS caused by complement dysregulation: new therapies on the horizon. Pediatr Nephrol. 2011;26(1):41-57.
    • (2011) Pediatr Nephrol , vol.26 , Issue.1 , pp. 41-57
    • Waters, A.M.1    Licht, C.2
  • 5
    • 84873650966 scopus 로고    scopus 로고
    • Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome
    • Tsai HM. Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med. 2013;126(3): 200-209.
    • (2013) Am J Med , vol.126 , Issue.3 , pp. 200-209
    • Tsai, H.M.1
  • 7
    • 38149128260 scopus 로고    scopus 로고
    • Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study
    • Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation. 2008;85(1):22-28.
    • (2008) Transplantation , vol.85 , Issue.1 , pp. 22-28
    • Siami, K.1    Kojouri, K.2    Swisher, K.K.3    Selby, G.B.4    George, J.N.5    Laszik, Z.G.6
  • 8
    • 45449119331 scopus 로고    scopus 로고
    • Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: Defining a disorder
    • George JN. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant. 2008;41(11):917-918.
    • (2008) Bone Marrow Transplant , vol.41 , Issue.11 , pp. 917-918
    • George, J.N.1
  • 9
    • 33748689295 scopus 로고    scopus 로고
    • Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    • Uderzo C, Bonanomi S, Busca A, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation. 2006; 82(5):638-644.
    • (2006) Transplantation , vol.82 , Issue.5 , pp. 638-644
    • Uderzo, C.1    Bonanomi, S.2    Busca, A.3
  • 10
    • 84857595082 scopus 로고    scopus 로고
    • Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation
    • Jodele S, Bleesing JJ, Mehta PA, et al. Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2012;16(2):E39-E42.
    • (2012) Pediatr Transplant , vol.16 , Issue.2
    • Jodele, S.1    Bleesing, J.J.2    Mehta, P.A.3
  • 11
    • 33745872977 scopus 로고    scopus 로고
    • Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment
    • Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006;17(7):1995-2005.
    • (2006) J Am Soc Nephrol , vol.17 , Issue.7 , pp. 1995-2005
    • Hingorani, S.1
  • 12
    • 34247401041 scopus 로고    scopus 로고
    • Significant increase in end-stage renal disease after hematopoietic stem cell transplantation
    • Cohen EP, Drobyski WR, Moulder JE. Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39(9):571-572.
    • (2007) Bone Marrow Transplant , vol.39 , Issue.9 , pp. 571-572
    • Cohen, E.P.1    Drobyski, W.R.2    Moulder, J.E.3
  • 13
    • 84874610717 scopus 로고    scopus 로고
    • Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
    • European Working Party on Complement Genetics in Renal Diseases
    • Bresin E, Rurali E, Caprioli J, et al European Working Party on Complement Genetics in Renal Diseases. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol. 2013;24(3): 475-486.
    • (2013) J Am Soc Nephrol , vol.24 , Issue.3 , pp. 475-486
    • Bresin, E.1    Rurali, E.2    Caprioli, J.3
  • 14
    • 84858633062 scopus 로고    scopus 로고
    • Eculizumab and refractory membranoproliferative glomerulonephritis
    • Radhakrishnan S, Lunn A, Kirschfink M, et al. Eculizumab and refractory membranoproliferative glomerulonephritis. N Engl J Med. 2012;366(12): 1165-1166.
    • (2012) N Engl J Med , vol.366 , Issue.12 , pp. 1165-1166
    • Radhakrishnan, S.1    Lunn, A.2    Kirschfink, M.3
  • 15
    • 38949155911 scopus 로고    scopus 로고
    • Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
    • Józsi M, Licht C, Strobel S, et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood. 2008;111(3):1512-1514.
    • (2008) Blood , vol.111 , Issue.3 , pp. 1512-1514
    • Józsi, M.1    Licht, C.2    Strobel, S.3
  • 17
    • 78349238830 scopus 로고    scopus 로고
    • Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation
    • Cho BS, Yahng SA, Lee SE, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90(8):918-926.
    • (2010) Transplantation , vol.90 , Issue.8 , pp. 918-926
    • Cho, B.S.1    Yahng, S.A.2    Lee, S.E.3
  • 18
    • 22344434696 scopus 로고    scopus 로고
    • Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation
    • Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(8):571-575.
    • (2005) Biol Blood Marrow Transplant , vol.11 , Issue.8 , pp. 571-575
    • Ho, V.T.1    Cutler, C.2    Carter, S.3
  • 19
    • 84874946877 scopus 로고    scopus 로고
    • Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
    • Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, Davies SM. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Transfusion. 2013;53(3):661-667.
    • (2013) Transfusion , vol.53 , Issue.3 , pp. 661-667
    • Jodele, S.1    Laskin, B.L.2    Goebel, J.3    Khoury, J.C.4    Pinkard, S.L.5    Carey, P.M.6    Davies, S.M.7
  • 20
    • 79955893687 scopus 로고    scopus 로고
    • Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT
    • Laskin BL, Goebel J, Davies SM, et al. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT. Bone Marrow Transplant. 2011;46(5):682-689.
    • (2011) Bone Marrow Transplant , vol.46 , Issue.5 , pp. 682-689
    • Laskin, B.L.1    Goebel, J.2    Davies, S.M.3
  • 21
    • 84872258720 scopus 로고    scopus 로고
    • Wellcome Trust Case Control Consortium 2. Insights into the genetic architecture of early stage age-related macular degeneration: A genome-wide association study meta-analysis
    • Holliday EG, Smith AV, Cornes BK, et al; Wellcome Trust Case Control Consortium 2. Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS ONE. 2013;8(1):e53830.
    • (2013) PLoS ONE , vol.8 , Issue.1
    • Holliday, E.G.1    Smith, A.V.2    Cornes, B.K.3
  • 22
    • 75649133611 scopus 로고    scopus 로고
    • Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
    • Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010;115(2): 379-387.
    • (2010) Blood , vol.115 , Issue.2 , pp. 379-387
    • Moore, I.1    Strain, L.2    Pappworth, I.3
  • 23
    • 77956231486 scopus 로고    scopus 로고
    • DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome
    • European DEAP-HUS Study Group
    • Zipfel PF, Mache C, Müller D, Licht C, Wigger M, Skerka C; European DEAP-HUS Study Group. DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome. Pediatr Nephrol. 2010;25(10): 2009-2019.
    • (2010) Pediatr Nephrol , vol.25 , Issue.10 , pp. 2009-2019
    • Zipfel, P.F.1    Mache, C.2    Müller, D.3    Licht, C.4    Wigger, M.5    Skerka, C.6
  • 24
    • 76949087440 scopus 로고    scopus 로고
    • Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
    • Abarrategui-Garrido C, Martínez-Barricarte R, López- Trascasa M, de Córdoba SR, Sánchez- Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood. 2009;114(19):4261-4271.
    • (2009) Blood , vol.114 , Issue.19 , pp. 4261-4271
    • Abarrategui-Garrido, C.1    Martínez-Barricarte, R.2    López- Trascasa, M.3    De Córdoba, S.R.4    Sánchez- Corral, P.5
  • 25
    • 84864925248 scopus 로고    scopus 로고
    • Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
    • Foltyn Zadura A, Zipfel PF, Bokarewa MI, et al. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther. 2012;14(4):R185.
    • (2012) Arthritis Res Ther , vol.14 , Issue.4
    • Foltyn Zadura, A.1    Zipfel, P.F.2    Bokarewa, M.I.3
  • 26
    • 70349441306 scopus 로고    scopus 로고
    • Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
    • Heinen S, Hartmann A, Lauer N, et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood. 2009;114(12):2439-2447.
    • (2009) Blood , vol.114 , Issue.12 , pp. 2439-2447
    • Heinen, S.1    Hartmann, A.2    Lauer, N.3
  • 29
    • 84873288473 scopus 로고    scopus 로고
    • Eculizumab for the treatment of preeclampsia/HELLP syndrome
    • Burwick RM, Feinberg BB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta. 2013;34(2):201-203.
    • (2013) Placenta , vol.34 , Issue.2 , pp. 201-203
    • Burwick, R.M.1    Feinberg, B.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.